DIN 02266695 — LITHMAX 300 MG
LITHMAX is a tablet (extended-release) of Lithium carbonate marketed by AA PHARMA INC. The full Lithium carbonate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02266695
- Brand name
- LITHMAX
- Active ingredient
- Lithium carbonate
- Strength
- 300 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- AA PHARMA INC
- Health Canada status
- MARKETED
- Drug class
- Antimanic agent / mood stabilizer
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Lithium carbonate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02242837 | APO-LITHIUM CARBONATE | 150 MG | CAPSULE | APOTEX INC | MARKETED |
| 02242838 | APO-LITHIUM CARBONATE | 300 MG | CAPSULE | APOTEX INC | DORMANT |
| 00461733 | CARBOLITH | 150 MG | CAPSULE | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 00236683 | CARBOLITH | 300 MG | CAPSULE | BAUSCH HEALTH, CANADA INC. | DORMANT |
| 02011239 | CARBOLITH | 600 MG | CAPSULE | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 02013231 | LITHANE | 150 MG | CAPSULE | SEARCHLIGHT PHARMA INC | MARKETED |
| 00406775 | LITHANE | 300 MG | CAPSULE | SEARCHLIGHT PHARMA INC | MARKETED |
| 02216132 | PMS-LITHIUM CARBONATE - CAP 150MG | 150 MG | CAPSULE | PHARMASCIENCE INC | MARKETED |
| 02216140 | PMS-LITHIUM CARBONATE - CAP 300MG | 300 MG | CAPSULE | PHARMASCIENCE INC | DORMANT |
| 02216159 | PMS-LITHIUM CARBONATE - CAP 600MG | 600 MG | CAPSULE | PHARMASCIENCE INC | DORMANT |